The Vanguard Group 13D and 13G filings for ClearPoint Neuro, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 2:35 pm Unchanged | 2024-09-30 | 13G | ClearPoint Neuro, Inc. CLPT | The Vanguard Group | 1,242,993 4.500% | 0 (Unchanged) | Filing |
| 2024-11-04 11:28 am Sale | 2024-09-30 | 13G | ClearPoint Neuro, Inc. CLPT | The Vanguard Group | 1,242,993 4.500% | -65,701 (-5.02%) | Filing |
| 2024-02-13 5:02 pm Purchase | 2023-12-29 | 13G | ClearPoint Neuro, Inc. CLPT | The Vanguard Group | 1,308,694 5.320% | 1,308,694 (New Position) | Filing |